Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.

RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...

Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...

GUO YALI/CHINA DAILY China is actively exploring innovative approaches to organizing biomedical research, betting that ...

A breakthrough quantum sensor has shown it can uncover hidden signals through overwhelming noise, paving the way for future ...

New materials are not created overnight; their development is often a slow, iterative process and in most cases, the work has ...

General purpose AI tools for science, such as Claude Science, promise to accelerate research. But which is right for you?

Building on recent successes, scientists are focused on a promising new frontier: sending tiny particles into the body to ...

Celldetective is an open-source software integrating segmentation, tracking, and event detection to perform high-throughput end-to-end study of dynamic cell interactions, without requiring coding ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

Rutgers Office for Research (OfR) leaders collaborated with researchers around the world to develop an artificial intelligence (AI) program that has the potential to revolutionize lab research.

Integrating case counts with genomic sequences quantifies real-time transmission advantages of viral variants.